Anna Bershteyn

4.7k total citations · 1 hit paper
69 papers, 2.3k citations indexed

About

Anna Bershteyn is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Anna Bershteyn has authored 69 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 22 papers in Epidemiology and 19 papers in General Health Professions. Recurrent topics in Anna Bershteyn's work include HIV/AIDS Research and Interventions (36 papers), Adolescent Sexual and Reproductive Health (18 papers) and HIV, Drug Use, Sexual Risk (18 papers). Anna Bershteyn is often cited by papers focused on HIV/AIDS Research and Interventions (36 papers), Adolescent Sexual and Reproductive Health (18 papers) and HIV, Drug Use, Sexual Risk (18 papers). Anna Bershteyn collaborates with scholars based in United States, South Africa and United Kingdom. Anna Bershteyn's co-authors include Darrell J. Irvine, James J. Moon, Soong Ho Um, Matthias T. Stephan, Daniel J. Klein, Andrew Phillips, Philip A. Eckhoff, John Stover, Timothy B. Hallett and Agnieszka Stachowiak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Anna Bershteyn

63 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

2010 621 citations Matthias T. Stephan, James J. Moon et al. profile →

Peers

Countries citing papers authored by Anna Bershteyn

Since Specialization

Citations

This map shows the geographic impact of Anna Bershteyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bershteyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bershteyn more than expected).

Fields of papers citing papers by Anna Bershteyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Bershteyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bershteyn. The network helps show where Anna Bershteyn may publish in the future.

Co-authorship network of co-authors of Anna Bershteyn

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Bershteyn. A scholar is included among the top collaborators of Anna Bershteyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Bershteyn. Anna Bershteyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimated contributions and future mitigation strategies for HIV risk around funeral practices in western Kenya: a mathematical modeling study 2025 ·BMC Medicine ·Samuel Mwalili, Duncan Kioi Gathungu, (unknown), (unknown), (unknown), (unknown), (unknown), Hae‐Young Kim, (unknown), Anna Bershteyn	0
2	Identifying gaps in the HIV treatment cascade in Africa: a model comparison study 2025 ·The Lancet Global Health ·Loveleen Bansi‐Matharu, (unknown), Daniel Citron, John Stover, Michael Pickles, Rowan Martin‐Hughes, Marie‐Claude Boily, Rose Nyirenda, Edinah Mudimu, (unknown), Leigh F. Johnson, (unknown), Valentina Cambiano, Dobromir Dimitrov, Jennifer S. Smith, Robert Glaubius, (unknown), (unknown), Andrew Phillips, Anna Bershteyn	2
3	Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis 2025 ·Journal of the International AIDS Society ·(unknown), Mia Moore, Lise Jamieson, Gesine Meyer‐Rath, Leigh F. Johnson, (unknown), Anna Bershteyn, Jennifer S. Smith, Valentina Cambiano, Loveleen Bansi‐Matharu, Andrew Phillips, (unknown), Ruanne V. Barnabas, Brett Hanscom, Deborah Donnell, Marie‐Claude Boily, Dobromir Dimitrov	0
4	Meeting Social Needs in a Crisis Context: Lessons Learned from Integrating the ‘Take Care Initiative’ into New York City’s Testing and Contact Tracing Program 2024 ·Journal of Urban Health ·(unknown), Margaret M. Paul, (unknown), Michelle M. Chau, (unknown), Nadia Islam, Lorna E. Thorpe, (unknown), Anna Bershteyn, Carolyn A. Berry	1
5	Geospatial patterns of progress towards UNAIDS ‘95-95-95’ targets and community vulnerability in Zambia: insights from population-based HIV impact assessments 2023 ·BMJ Global Health ·Diego F. Cuadros, (unknown), (unknown), Daniel Citron, (unknown), (unknown), (unknown), Lloyd Mulenga, (unknown), Khozya Zyambo, Anna Bershteyn	3
6	Social distancing and mask-wearing could avoid recurrent stay-at-home restrictions during COVID-19 respiratory pandemic in New York City 2022 ·Scientific Reports ·Hae‐Young Kim, Anna Bershteyn, Jessica B. McGillen, (unknown), Julia Sisti, (unknown), (unknown), (unknown), R. Scott Braithwaite	6
7	Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study 2021 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Britta L. Jewell, Laura B. Balzer, Tamara D. Clark, Edwin D. Charlebois, Dalsone Kwarisiima, Moses R. Kamya, Diane V. Havlir, Maya Petersen, Anna Bershteyn	5
8	Intensive Care Unit Capacity and Its Associated Risk Factors During the COVID-19 Surge in the Republic of Korea: Analysis Using Nationwide Health Claims Data 2020 ·SHILAP Revista de lepidopterología ·Lee Sh, Park Sy, (unknown), (unknown), (unknown), Park Jh, (unknown), (unknown), Niket Thakkar, Prashanth Selvaraj, Anna Bershteyn, (unknown)	0
9	Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90‐90‐90 in sub‐Saharan Africa – a systematic review and meta‐analysis 2020 ·Journal of the International AIDS Society ·(unknown), Diana M. Tordoff, (unknown), Adam Akullian, Anna Bershteyn, Michelle Morrison, Geoff P. Garnett, Ann Duerr, Paul K. Drain	29
10	<p>Intensive Care Unit Capacity and Its Associated Risk Factors During the COVID-19 Surge in the Republic of Korea: Analysis Using Nationwide Health Claims Data</p> 2020 ·Risk Management and Healthcare Policy ·Seung Heon Lee, So-Youn Park, (unknown), (unknown), (unknown), Jong-Hak Park, Jae Seok Park, Hae‐Young Kim, Niket Thakkar, Prashanth Selvaraj, Anna Bershteyn, In‐Hwan Oh	3
11	The future of a partially effective HIV vaccine: assessing limitations at the population level 2019 ·International Journal of Public Health ·Christian Selinger, Dobromir Dimitrov, Philip A. Welkhoff, Anna Bershteyn	3
12	Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response 2019 ·Clinical Microbiology Reviews ·Paul K. Drain, Jienchi Dorward, Andrew T. Bender, Lorraine Lillis, Francesco Marinucci, Jilian A. Sacks, Anna Bershteyn, David S. Boyle, Jonathan D. Posner, Nigel Garrett	79
13	Sexual partnership age pairings and risk of HIV acquisition in rural South Africa 2017 ·AIDS ·Adam Akullian, Anna Bershteyn, Daniel J. Klein, Alain Vandormael, Till Bärnighausen, Frank Tanser	52
14	Geographic coverage of male circumcision in western Kenya 2017 ·Medicine ·Adam Akullian, (unknown), Daniel J. Klein, Jacob Odhiambo, Anna Bershteyn	10
15	Age-targeted HIV treatment and primary prevention as a ‘ring fence’ to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South Africa 2016 ·International Health ·Anna Bershteyn, Daniel J. Klein, Philip A. Eckhoff	16
16	Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era 2015 ·The Lancet Global Health ·Jeffrey W. Eaton, Nicolas Bacaër, Anna Bershteyn, Valentina Cambiano, Anne Cori, Rob Dorrington, Christophe Fraser, Chaitra Gopalappa, Jan A. C. Hontelez, Leigh F. Johnson, Daniel J. Klein, Andrew Phillips, Carel Pretorius, John Stover, T. Rehle, Timothy B. Hallett	40
17	A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns 2013 ·BMC Systems Biology ·Anna Bershteyn, Philip A. Eckhoff	14
18	Immunogenicity of Membrane-bound HIV-1 gp41 Membrane-proximal External Region (MPER) Segments Is Dominated by Residue Accessibility and Modulated by Stereochemistry 2013 ·Journal of Biological Chemistry ·Mikyung Kim, Likai Song, James J. Moon, (unknown), Anna Bershteyn, Melissa C. Hanson, Derek W. Cain, (unknown), Garnett Kelsoe, Gerhard Wagner, Darrell J. Irvine, Ellis L. Reinherz	36
19	Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses 2011 ·Nature Materials ·James Moon, Heikyung Suh, Anna Bershteyn, Matthias T. Stephan, Haipeng Liu, Bonnie Huang, (unknown), Shoukang Luo, Soong Ho Um, Htet A. Khant, (unknown), (unknown), Wah Chiu, Darrell J. Irvine	15
20	Nanobiomechanics of Repair Bone Regenerated by Genetically Modified Mesenchymal Stem Cells 2008 ·Tissue Engineering Part A ·Kuangshin Tai, Gadi Pelled, Dmitriy Sheyn, Anna Bershteyn, Lin Han, Ilan Kallai, Yoram Zilberman, Christine Ortiz, Dan Gazit	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact